Neurogene (NGNE) Enterprise Value (2018 - 2025)
Historic Enterprise Value for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to -$265.4 million.
- Neurogene's Enterprise Value fell 9095.21% to -$265.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$265.4 million, marking a year-over-year decrease of 9095.21%. This contributed to the annual value of -$312.4 million for FY2024, which is 5845.49% down from last year.
- Latest data reveals that Neurogene reported Enterprise Value of -$265.4 million as of Q3 2025, which was down 9095.21% from -$274.5 million recorded in Q2 2025.
- Neurogene's Enterprise Value's 5-year high stood at -$78.5 million during Q3 2023, with a 5-year trough of -$312.4 million in Q4 2024.
- In the last 3 years, Neurogene's Enterprise Value had a median value of -$169.5 million in 2024 and averaged -$186.2 million.
- Over the last 5 years, Neurogene's Enterprise Value had its largest YoY gain of 5845.49% in 2024, and its largest YoY loss of 10318.93% in 2024.
- Neurogene's Enterprise Value (Quarter) stood at -$197.2 million in 2023, then tumbled by 58.45% to -$312.4 million in 2024, then grew by 15.04% to -$265.4 million in 2025.
- Its Enterprise Value was -$265.4 million in Q3 2025, compared to -$274.5 million in Q2 2025 and -$292.6 million in Q1 2025.